Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1981-10-29
pubmed:abstractText
Gelonin, a plant protein which can powerfully reduce the protein-synthetic capacity of ribosome preparations, was covalently coupled to anti-Thy1.2 antibody. The conjugate was prepared using N-succinimidyl-3-(2-pyridyldithio)propionate which generates a disulphide linkage between the component molecules. Two conjugate fractions were obtained with Mr of 180 000 and greater than 200 000. After its linkage of the antibody, gelonin suppressed those Thy1.1-bearing T lymphocytes from AKR mice which will respond to phytohaemagglutinin and concanavalin A in tissue culture. The [3H]leucine incorporation with the T-cell mitogens was inhibited by 50% with the 180 000-Mr fraction at a concentration of 0.4 nM and with the greater than 200 000-Mr fraction of pM. Unconjugated gelonin induced comparable reductions in T-cell responsiveness but at concentrations of 30 nM. The conjugates exerted little or no effect upon B lymphocytes or T lymphocytes from CBA mice (Thy1.2 + ve). Thy1.1-expressing AKR lymphoma cell lines, AKR-A and BW5147, were found to be sensitive to the conjugates, albeit much less so than the normal T lymphocytes. The conjugates injected in vivo significantly prolonged the life of CBA mice bearing in an AKR-A lymphoma allograft. It is concluded that gelonin can, by its linkage to an antibody, be rendered cytotoxic with a potency to match or exceed those of the toxins abrin and ricin.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0014-2956
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
116
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
447-54
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:6790277-Animals, pubmed-meshheading:6790277-Antibodies, pubmed-meshheading:6790277-Antibodies, Monoclonal, pubmed-meshheading:6790277-Antigen-Antibody Complex, pubmed-meshheading:6790277-Cell Line, pubmed-meshheading:6790277-Cytotoxicity, Immunologic, pubmed-meshheading:6790277-Disulfides, pubmed-meshheading:6790277-Glycoproteins, pubmed-meshheading:6790277-Immunotherapy, pubmed-meshheading:6790277-Lymphocyte Activation, pubmed-meshheading:6790277-Lymphoma, pubmed-meshheading:6790277-Mice, pubmed-meshheading:6790277-Mice, Inbred AKR, pubmed-meshheading:6790277-Molecular Weight, pubmed-meshheading:6790277-Neoplasms, Experimental, pubmed-meshheading:6790277-Phytohemagglutinins, pubmed-meshheading:6790277-Plant Proteins, pubmed-meshheading:6790277-Ribosome Inactivating Proteins, Type 1, pubmed-meshheading:6790277-T-Lymphocytes
pubmed:year
1981
pubmed:articleTitle
Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't